pwallace said...
tall allen- that <0.03 number was the one i was looking for in re: to biochemical reccurance, but for some reason i thought it was <0.02. some sites say it needs to be even lower - 0.003 for example as per johns hopkins: http://urology.jhu.edu/newsletter/2012/prostate_cancer_2012_14.php
You seem to have several concepts confused. Let me try to clarify:
"undetectable" means less than the specific PSA test at that lab can reliably detect. The JH article you referenced is only saying that what was undetectable in the 20th century is very much detectable in the 21st century. In fact there are now superultrasensitive PSA tests that can detect amounts of PSA as low as 0.003. But what you would use that test for is beyond me.
"Biochemical recurrence (BCR)" was
arbitrarily set at 0.2 back in the day before uPSA was readily available. It has no real meaning beyond being an arbitrary benchmark. The related idea of "salvage radiation" is radiation that is given after BCR is reached. This has been mostly discarded.
"Unfavorable uPSA" is perhaps a better way of thinking about
it. It is the uPSA at which one should think about
"early salvage" radiation after prostatectomy.
For example, a uPSA of 0.01 is detectable, it is not a BCR, and most doctors would consider it as favorable, and not a reason to consider early salvage RT. A PSA of 0.03 with adverse pathology is detectable, is not a BCR (although it reliably predicts BCR), and many ROs would consider it as unfavorable and a valid reason to consider early salvage.